67197-54-0 Usage
Description
(4-BROMO-2-CHLOROPHENYL)ACETONOTRILE, with the molecular formula C8H6BrClN, is a nitrile compound characterized by a carbon triple-bonded to a nitrogen atom. It is a colorless to pale yellow liquid with a pleasant odor, and should be handled with care due to its toxic nature if swallowed, inhaled, or absorbed through the skin.
Used in Pharmaceutical Industry:
(4-BROMO-2-CHLOROPHENYL)ACETONOTRILE is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of various medicinal compounds.
Used in Agrochemical Industry:
(4-BROMO-2-CHLOROPHENYL)ACETONOTRILE is used as an intermediate in the synthesis of agrochemicals, playing a role in the production of substances that help control, eliminate, or prevent pests in agriculture.
Used in Organic Compounds Synthesis:
(4-BROMO-2-CHLOROPHENYL)ACETONOTRILE is used as an intermediate in the synthesis of organic compounds, contributing to the formation of various chemical entities for different applications.
Used in Dyes and Pigments Production:
(4-BROMO-2-CHLOROPHENYL)ACETONOTRILE is used in the production of dyes and pigments, where its chemical properties contribute to the creation of a range of colorants for various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 67197-54-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,1,9 and 7 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 67197-54:
(7*6)+(6*7)+(5*1)+(4*9)+(3*7)+(2*5)+(1*4)=160
160 % 10 = 0
So 67197-54-0 is a valid CAS Registry Number.
67197-54-0Relevant articles and documents
HETEROCYCLIC FXR MODULATORS
-
, (2018/05/16)
The present technology is directed to compounds of formula (I), compositions, and methods related to modulation of FXR. In particular, the present compounds and compositions may be used to treat FXR-mediated disorders and conditions, including, e.g., liver disease, hyperlipidemia, hypercholesteremia, obesity, metabolic syndrome, cardiovascular disease, gastrointestinal disease, and atherosclerosis, and renal disease.
SERINE/THREONINE KINASE INHIBITORS
-
Paragraph 0342; 0340, (2015/02/19)
Compounds having the formula I wherein R1, R2, R3, R4, R5, Ra, Rb, Rc, Rd, Re, n, r, s and t are as defined herein and which compounds are inhibitors of PAK1. Also disclosed are compositions and methods for treating cancer and hyperproliferative disorders.
2- PYRIDONE COMPOUND
-
Paragraph 0361; 0362, (2016/10/08)
PROBLEM TO BE SOLVED: To provide a compound that has excellent glucokinase (GK) activating action and is useful as a pharmaceutical. SOLUTION: The present invention provides a 2-pyridone compound represented by formula [1], and a tautomer or stereoisomer of the compound, or their pharmacologically acceptable salts, or their solvates (where R1 is RA-ZA-; RA is any of a carboxy group, a sulfo group or formula [5]). COPYRIGHT: (C)2016,JPOandINPIT
